{"id":2112,"date":"2024-07-25T12:36:04","date_gmt":"2024-07-25T12:36:04","guid":{"rendered":"https:\/\/capiton.de\/?p=2112"},"modified":"2025-02-25T12:39:31","modified_gmt":"2025-02-25T12:39:31","slug":"portfolio-company-kd-pharma-group-acquires-dsm-firmenichs-marine-lipids-omega-3-business","status":"publish","type":"post","link":"https:\/\/capiton.de\/en\/portfolio-company-kd-pharma-group-acquires-dsm-firmenichs-marine-lipids-omega-3-business\/","title":{"rendered":"Portfolio Company KD Pharma Group acquires dsm-firmenich\u2019s Marine Lipids Omega-3 Business"},"content":{"rendered":"\n<p><strong>July 2025<\/strong>\u00a0\u2013\u00a0KD Pharma Group (\u201cKD Pharma\u201d), a leading CDMO in pharmaceutical and nutritional lipids, announces the acquisition of dsm-firmenich\u2019s Marine Lipids business. As part of the transaction, dsm-firmenich will obtain a minority stake in KD Pharma and become co-shareholder alongside the capiton Omega continuation fund vehicles and other minority shareholders.<\/p>\n\n\n\n<p>The transaction will close in the course of 2024 subject to customary regulatory approvals, and includes dsm-firmenich\u2019s Marine Lipids fish oil omega-3 business for the dietary supplement and pharma markets, together with the production facilities in Piura, Peru, and Mulgrave, Canada.<\/p>\n\n\n\n<p>This transaction will create a well-equipped market player in marine lipids by combining the best of the two companies and respective expertise, with the scale of dsm-firmenich\u2019s Piura and Mulgrave sites and the high concentration capability of KD Pharma. The enlarged KD Pharma Group will benefit from the expansion into a significantly wider range of products and customization opportunities supported by broadened manufacturing capacity.<\/p>\n\n\n\n<p>Oscar Groet, CEO of KD Pharma said, \u201cWe are thrilled to welcome dsm-firmenich\u2019s Marine Lipids portfolio into KD Pharma, a move that aligns perfectly with our strategic vision of being technology leaders in lipids and enhancing our ability to innovate and deliver exceptional value to our customers.\u201d<\/p>\n\n\n\n<p>For more information, visit&nbsp;<a href=\"https:\/\/kdpharmagroup.com\/news\/kd-pharma-group-announces-acquisition-dsm-firmenichs-marine-lipids-business\">KD Pharma Group News<\/a><\/p>\n\n\n\n<p>capiton AG and KD Pharma Group were advised by Jefferies, acting as buyside advisor, CMS Hasche Sigle, Baker McKenzie, A&amp;O Shearman, EY, BDO, Herter &amp; Co. \u2013 A Teneo Company, Roland Berger and Howden M&amp;A. The transaction was notarized by Dr. Patrick Auerbach (NEON) and is subject to customary regulatory approvals.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>July 2025\u00a0\u2013\u00a0KD Pharma Group (\u201cKD Pharma\u201d), a leading CDMO in pharmaceutical and nutritional lipids, announces the acquisition of dsm-firmenich\u2019s Marine Lipids business. As part of the transaction, dsm-firmenich will obtain a minority stake in KD Pharma and become co-shareholder alongside the capiton Omega continuation fund vehicles and other minority shareholders. The transaction will close in [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":2104,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2112","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-unkategorisiert"],"acf":[],"_links":{"self":[{"href":"https:\/\/capiton.de\/en\/wp-json\/wp\/v2\/posts\/2112","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/capiton.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/capiton.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/capiton.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/capiton.de\/en\/wp-json\/wp\/v2\/comments?post=2112"}],"version-history":[{"count":2,"href":"https:\/\/capiton.de\/en\/wp-json\/wp\/v2\/posts\/2112\/revisions"}],"predecessor-version":[{"id":2114,"href":"https:\/\/capiton.de\/en\/wp-json\/wp\/v2\/posts\/2112\/revisions\/2114"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/capiton.de\/en\/wp-json\/wp\/v2\/media\/2104"}],"wp:attachment":[{"href":"https:\/\/capiton.de\/en\/wp-json\/wp\/v2\/media?parent=2112"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/capiton.de\/en\/wp-json\/wp\/v2\/categories?post=2112"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/capiton.de\/en\/wp-json\/wp\/v2\/tags?post=2112"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}